Condition

Neoplasms, Pulmonary

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 10 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials10

Recruiting1

Common interventions13

Lead sponsors shown6

Clinical trials

10 shown

Precision Lung Cancer Survivorship Care InterventionNCT05857995 · 2024-08-16

RECRUITING

Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare®NCT05011890 · 2021-09-01

COMPLETED

Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C MutationNCT04699188 · 2021-02-24

ACTIVE_NOT_RECRUITING

Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung CancerNCT02410603 · 2016-12-01

COMPLETED

MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)NCT02673021 · 2016-06-08

TERMINATED

Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell CarcinomaNCT02549638 · 2015-04-08

TERMINATED

A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ SystemNCT02370303 · 2014-08-01

COMPLETED

The Need of Fiberoptic Bronchoscopy for Placing an Endobronchial BlockerNCT02133235 · 2014-05-01

COMPLETED

A Phase I Study of iPS Cell Generation From Patients With COPDNCT01860898 · 2009-09-01

COMPLETED

Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based ChemotherapyNCT00290017 · 2006-02-01

TERMINATED

Common interventions

auscultationPROCEDURE1 conventionalPROCEDURE1 DNA ExtractionGENETIC1 Enhanced Usual CareBEHAVIORAL1 JDQ443DRUG1 Kentucky LEADS Collaborative Lung Cancer Survivorship Care ProgramBEHAVIORAL1 Microwave ablationPROCEDURE1 Moovcare® useDEVICE1 pemetrexedDRUG1 Skin BiopsyOTHER1 talabostatDRUG1 tislelizumabBIOLOGICAL1 TNO155DRUG1

Leading sponsors

Mayo Clinic 5 Jerod L Stapleton, PhD 1 National Taiwan University Hospital 1 Novartis Pharmaceuticals 1 Point Therapeutics 1 UNC Lineberger Comprehensive Cancer Center 1

Trial status mix

COMPLETED5

TERMINATED3

ACTIVE_NOT_RECRUITING1

RECRUITING1

Phase mix

NA5

PHASE11

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.